Newsletter
Every new paper in this field, in your inbox.
A shift towards neoadjuvant therapy in resectable pancreatic adenocarcinoma may enhance surgical success rates. This approach addresses micro-metastatic disease present in many patients, highlighting the necessity of systemic therapy irrespective of resectability. It further allows for tailored treatment selections based on individual tumor biology. Evidence…
Analysis of 364 hepatocellular carcinoma patients revealed that age alone does not significantly affect overall or tumor-free survival outcomes after liver resection. Higher postoperative morbidity and longer hospital stays were observed in younger patients under 60, while the elderly exhibited no early mortality. Despite higher…
A meta-analysis of 8,801 patients indicated that early endoscopic retrograde cholangiopancreatography (ERCP) for acute biliary pancreatitis is as safe as delayed ERCP. Notably, early ERCP significantly reduces hospital stay without increasing complications or mortality rates. These findings suggest that early intervention could enhance patient outcomes…
A comprehensive risk model for liver resection outcomes has been developed using data from 73,861 patients in Japan. Key findings revealed 30-day and in-hospital mortality rates of 0.9% and 1.7%, respectively. Significant risk factors for postoperative complications included trisectionectomy, hepatectomy for gallbladder cancer, and poor…
A novel approach to matching patients with pancreatic ductal adenocarcinoma (PDAC) to effective chemotherapy has shown significant promise. Patient-derived organoids (PDOs) matched 91% of patients to standard treatments, improving CA 19-9 markers and lymph node staging. Notably, those who received therapies well-aligned with their PDO…
Patients undergoing minimally invasive distal pancreatectomy without abdominal drains experienced significantly lower rates of postoperative pancreatic fistula (3.4% vs. 27.6%) and abdominal collections (3.4% vs. 31.0%), along with a shorter hospital stay (5 days vs. 9 days). These findings suggest that not using drains during…
A study reviewing 56 cases presented at the novel benign liver and pancreas rounds highlights the effectiveness of a multidisciplinary case conference in managing benign hepatopancreatobiliary diseases. The discussions resulted in a change or adjustment in the proposed management plan for 82% of cases, with…
GAME-SCORE demonstrates predictive value for pathological and radiological responses to neoadjuvant chemotherapy in colorectal liver metastases. High-risk GAME-SCORE patients exhibited significantly lower pathological response rates (82.6%) and increased radiological progression (10%) compared to low (3.8%) and moderate (3.5%) risk groups. Furthermore, multivariable analysis identified high-risk…
In a study of 2,180 patients who underwent major hepatobiliary and pancreatic surgery, 8.4% experienced moderate-to-severe pain within 24 hours post-operation. Key independent risk factors identified include younger age, lower body mass index, open surgical procedures, and the use of sufentanil for analgesia. Additionally, inadequate…
In a study involving 192 patients with combined hepatocellular-cholangiocarcinoma, tumor burden score (TBS) outperformed standard primary liver cancer staging in predicting post-surgical prognosis. Stratified into low, medium, and high TBS, patient outcomes declined as TBS increased. TBS proved to be an independent prognostic factor across…
